PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 27 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $330,065 | +20.2% | 198,835 | +44.8% | 0.00% | – |
Q2 2023 | $274,594 | +59.1% | 137,297 | +67.1% | 0.00% | – |
Q1 2023 | $172,570 | +1432.9% | 82,176 | +900.1% | 0.00% | – |
Q4 2022 | $11,258 | +25.1% | 8,217 | 0.0% | 0.00% | – |
Q3 2022 | $9,000 | 0.0% | 8,217 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | -64.0% | 8,217 | -65.6% | 0.00% | – |
Q1 2022 | $25,000 | -97.7% | 23,917 | -98.2% | 0.00% | – |
Q4 2021 | $1,075,000 | -64.6% | 1,292,963 | -43.4% | 0.00% | – |
Q3 2021 | $3,039,000 | -14.5% | 2,285,075 | +22.7% | 0.00% | – |
Q2 2021 | $3,556,000 | – | 1,861,819 | +3723538.0% | 0.00% | – |
Q1 2021 | $0 | – | 50 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 50 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 50 | +400.0% | 0.00% | – |
Q1 2020 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,413,487 | $2,513,000 | 0.04% |
CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $27,000 | 0.02% |
MEITAV INVESTMENT HOUSE LTD | 244,332 | $256,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,790 | $139,000 | 0.00% |
IHT Wealth Management, LLC | 22,000 | $23,000 | 0.00% |
Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3,027 | $3,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
DAVENPORT & Co LLC | 22,000 | $23,000 | 0.00% |